[go: up one dir, main page]

NO20001894L - Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer - Google Patents

Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer

Info

Publication number
NO20001894L
NO20001894L NO20001894A NO20001894A NO20001894L NO 20001894 L NO20001894 L NO 20001894L NO 20001894 A NO20001894 A NO 20001894A NO 20001894 A NO20001894 A NO 20001894A NO 20001894 L NO20001894 L NO 20001894L
Authority
NO
Norway
Prior art keywords
drugs
treatment
tnf antagonists
septic diseases
septic
Prior art date
Application number
NO20001894A
Other languages
English (en)
Other versions
NO20001894D0 (no
Inventor
Hartmut Kupper
Martin Kaul
Juergen Eiselstein
Lothar Daum
Joachim Kempeni
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO20001894L publication Critical patent/NO20001894L/no
Publication of NO20001894D0 publication Critical patent/NO20001894D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20001894A 1997-10-23 2000-04-12 Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer NO20001894D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19746868A DE19746868A1 (de) 1997-10-23 1997-10-23 Verwendung von TNF-Antagonisten als Arzneimittel zur Behandlung von septischen Erkrankungen
PCT/EP1998/006545 WO1999021582A2 (de) 1997-10-23 1998-10-15 Verwendung von tnf-antagonisten als arzneimittel zur behandlung von septischen erkrankungen

Publications (2)

Publication Number Publication Date
NO20001894L true NO20001894L (no) 2000-04-12
NO20001894D0 NO20001894D0 (no) 2000-04-12

Family

ID=7846420

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001894A NO20001894D0 (no) 1997-10-23 2000-04-12 Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer

Country Status (13)

Country Link
EP (1) EP1024831A2 (no)
JP (1) JP2001521009A (no)
KR (1) KR20010024549A (no)
CN (1) CN1163272C (no)
AU (1) AU756167B2 (no)
BR (1) BR9813114A (no)
CA (1) CA2306790A1 (no)
DE (1) DE19746868A1 (no)
HU (1) HUP0100105A3 (no)
IL (1) IL135083A0 (no)
NO (1) NO20001894D0 (no)
WO (1) WO1999021582A2 (no)
ZA (1) ZA989615B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76640C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
RU2309732C1 (ru) 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
WO2012007845A2 (en) 2010-07-15 2012-01-19 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
WO2012007839A2 (en) 2010-07-15 2012-01-19 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
EP2415461B1 (en) * 2010-07-24 2012-10-31 Roche Diagnostics GmbH Stabilization of interleukin 6 in serum based solutions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229922A (en) * 1988-07-18 1992-04-28 Chiron Corp Monoclonal antibodies specifically binding cachectin (tumor necrosis factor) and compositions
GB9109645D0 (en) * 1991-05-03 1991-06-26 Celltech Ltd Recombinant antibodies
NZ278607A (en) * 1994-02-07 1999-05-28 Knoll Ag Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above

Also Published As

Publication number Publication date
CN1163272C (zh) 2004-08-25
AU1228499A (en) 1999-05-17
EP1024831A2 (de) 2000-08-09
CN1277556A (zh) 2000-12-20
ZA989615B (en) 2000-04-20
HUP0100105A2 (hu) 2001-05-28
HUP0100105A3 (en) 2003-08-28
JP2001521009A (ja) 2001-11-06
WO1999021582A3 (de) 1999-07-15
WO1999021582A2 (de) 1999-05-06
NO20001894D0 (no) 2000-04-12
CA2306790A1 (en) 1999-05-06
KR20010024549A (ko) 2001-03-26
IL135083A0 (en) 2001-05-20
BR9813114A (pt) 2000-08-15
DE19746868A1 (de) 1999-04-29
AU756167B2 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
DE60028358D1 (de) Hmg1 antagonisten zur behandlung von entzündungen
NO995221D0 (no) Sulfonamider for behandling av endotelinmedierte sykdommer
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DK0730864T3 (da) Lægemiddel til behandling af inflammatoriske hjertesygdomme
EE200300214A (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis
FI971527L (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
NO20012106D0 (no) Middel for behandling av benpatobolisme
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
NO20020784D0 (no) Medikament for behandling av brudd
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO991164D0 (no) Farmas°ytisk preparat for behandling av virussykdommer
NO982562D0 (no) Sammensetning for behandling av smerte
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20003799L (no) Innkorporering av kolesterol senkende midler i konfekt- dosisformer
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
DE60043648D1 (de) Medikamente zur behandlung von periodontalen erkrankungen
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
DK0900078T3 (da) Anvendelse af benzonaphthalenderivater til fremstilling af lægemidler til behandling af sygdomme i nervesystemet
NO995940D0 (no) Anvendelse av leptin antagonister for behandling av diabetes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application